Universal Vision Biotechnology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 3,494.06 million compared to TWD 2,631.8 million a year ago. Net income was TWD 850.39 million compared to TWD 595.43 million a year ago.

Basic earnings per share from continuing operations was TWD 10.0377 compared to TWD 7.0283 a year ago. Diluted earnings per share from continuing operations was TWD 10.0189 compared to TWD 7.0189 a year ago.